Group One Trading, L.P. Forte Biosciences, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

Shares

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 14, 2024	SELL	$0.46 - $0.78 $234 - $397	-510 Reduced 3.51%	14,017 $7,000
Q1 2024 May 10, 2024	SELL	$0.48 - $0.85 $624 - $1,105	-1,300 Reduced 8.21%	14,527 $10,000
Q3 2023 Nov 09, 2023	SELL	$0.65 - $1.04 $338 - $540	-520 Reduced 3.18%	15,827 $10,000
Q2 2023 Aug 09, 2023	BUY	$0.98 - $1.11 $10,294 - $11,660	10,505 Added 179.82%	16,347 $17,000
Q1 2023 May 12, 2023	SELL	$0.98 - $1.06 $2,005 - $2,168	-2,046 Reduced 25.94%	5,842 $5,000
Q4 2022 Feb 09, 2023	SELL	$0.96 - $28.0 $10,718 - $312,620	-11,165 Reduced 58.6%	7,888 $7,000
Q1 2022 May 12, 2022	SELL	$1.21 - $2.24 $6,478 - $11,992	-5,354 Reduced 21.94%	19,053 $28,000
Q4 2021 Feb 11, 2022	SELL	$2.02 - $3.36 $27,366 - $45,521	-13,548 Reduced 35.69%	24,407 $52,000
Q3 2021 Nov 12, 2021	BUY	$2.96 - $36.67 $112,346 - $1.39 Million	37,955 New	37,955 $112,000
Q3 2020 Nov 12, 2020	SELL	$14.71 - $50.69 $2,456 - $8,465	-167 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$13.9 - $24.6 $2,321 - $4,108	167 New	167 $2,000

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$3.19 Million
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $371M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.